Intelerad is now a GE HealthCare company. Learn more about this partnership.

Intelerad

How Breast Imaging Providers Should Prepare for the Find It Early Act

If the Find It Early Act is passed, breast imaging providers should prepare for a sharp increase in diagnostic imaging demand.
January 7, 2026
If the Find It Early Act is passed, breast imaging providers should prepare for a sharp increase in diagnostic imaging demand by strengthening patient tracking, streamlining follow-up workflows, and ensuring their breast imaging operations can scale without added complexity. Preparing now means putting the right systems in place to manage follow-ups, track risk, and maintain compliance at scale. InteleScreen™ is purpose-built to help breast imaging organizations do exactly that.

What Is the Find It Early Act?

The Find It Early Act is proposed U.S. legislation that would require health insurance plans to cover screening and diagnostic breast imaging—such as mammography, ultrasound, and breast MRI—without patient cost-sharing. Reintroduced in November 2025, the bill aims to expand coverage for mammograms, breast ultrasounds, and MRIs. The goal is to remove financial barriers that delay early detection—especially for women with dense breasts, where mammography alone may miss tumors. Early-stage breast cancer has a 99% five-year survival rate, underscoring the importance of timely diagnostic access.

Why Does the Find It Early Act Matter?

Breast imaging providers, radiology practices, and health systems offering screening and diagnostic breast imaging will be directly impacted. Expanded coverage means more patients will move from screening to diagnostic exams without delay. For providers, expanded coverage is expected to drive:
  • Higher volumes of diagnostic mammography, breast ultrasound, and breast MRI
  • More patients moving from screening to diagnostic follow-up
  • Greater urgency around timely results and communication
  • Increased regulatory and documentation demands
While this improves access, it places additional operational pressure on imaging programs already managing staffing shortages, high exam complexity, and strict regulatory requirements, including compliance with the Mammography Quality Standards Act (MQSA).

What Will Change for Breast Imaging Workflows?

Breast imaging workflows will become more time-sensitive, data-intensive, and coordination-heavy. Expanded access means more diagnostic cases moving through existing systems, often requiring multiple exams, risk-based decision-making, and precise follow-up tracking. Providers will need to prioritize time-sensitive cases, standardize reporting, and ensure no patients are lost between recommendation and action. Without dedicated tracking and workflow tools, these changes can lead to missed follow-ups, compliance risk, and delayed care.

How Should Providers Prepare for the Find It Early Act?

Providers should prepare by implementing dedicated breast imaging solutions that automate patient tracking, standardize workflows, and support timely communication at scale. Key preparation priorities include:
  1. Dedicated patient tracking – Providers need reliable ways to capture risk identifiers, track follow-up recommendations, and ensure patients stay on track for their next recommended exam.
  2. Streamlined patient communication – As volumes increase, manual letter generation and follow-up outreach become unsustainable. Automated communication helps ensure timely follow-ups and improves patient satisfaction.
  3. Built-in regulatory compliance – With more diagnostic exams comes increased reporting and audit requirements. Automated MQSA tracking and reporting reduce administrative burden and risk.
  4. Workflow efficiency and turnaround time – Radiology teams need tools that simplify time-intensive tasks, reduce reporting friction, and support same-day or faster results.

What is InteleScreen?

InteleScreen is a dedicated patient tracking and workflow solution designed specifically for breast and lung imaging organizations. Built to support early detection programs, InteleScreen captures risk identifiers, streamlines information sharing, and manages patient communication across the screening-to-diagnosis continuum. It helps providers operationalize early detection at scale while maintaining consistency, compliance, and efficiency. InteleScreen enables breast imaging teams to handle higher diagnostic volumes without losing visibility, control, or compliance. Key benefits include:
  • Optimized communication – InteleScreen manages patient letter communications and follow-up notifications, helping ensure timely care and improving patient satisfaction by keeping everyone aligned on next steps.
  • Automated MQSA tracking and reporting – With automated MQSA tracking and reporting, InteleScreen generates comprehensive audit reports at the click of a button—simplifying compliance and audit preparation.
  • Improved turnaround time – Productivity enhancements such as single-click negative reports and same-day results help reduce report turnaround times and ease radiologist workload.
  • Customized workflows – InteleScreen supports structured reporting and integrates seamlessly with third-party health record and dictation systems, enabling workflows tailored to each organization’s needs.

InteleScreen’s Real-World Impact

When risk assessment and follow-up tracking are embedded directly into screening workflows, care delivery changes at a practical, day-to-day level. Intelerad client Dr. Parghi and his team have described how a more structured, technology-enabled screening approach improved consistency in risk-based decision-making, supported earlier escalation to advanced imaging when clinically appropriate, and reduced gaps in follow-up care. Dr. Parghi has also emphasized the importance of removing friction from breast screening workflows, particularly for patients who fall outside “average-risk” categories. Advances in AI pattern recognition in InteleScreen have helped identify subtle findings. Parghi noted that without the aid of AI, 95-100% of these wrinkle-like cases would likely go undetected.

Preparing Now Positions Providers for What’s Next

The Find It Early Act has not yet been passed, but its potential impact on breast imaging demand is clear. Providers that invest now in scalable breast imaging workflows will be better positioned to manage increased demand, support their teams, and deliver timely diagnostic care if access expands. InteleScreen offers a practical way to move from policy readiness to operational execution. By strengthening patient tracking, streamlining follow-ups, and adopting purpose-built solutions like InteleScreen, imaging organizations can move from intent to execution—supporting earlier detection as a sustainable, system-wide capability. Learn how InteleScreen can help your organization prepare for what’s next, book a demo, or watch a self-guided demo to see it in action.

Related Blogs